These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 35289354)

  • 41. Efficacy and Safety of Botulinum Toxin Type A in the Treatment of Glabellar Lines: A Meta-Analysis of Randomized, Placebo-Controlled, Double-Blind Trials.
    Guo Y; Lu Y; Liu T; Zhou Y; Yang P; Zhu J; Chen L; Yang Q
    Plast Reconstr Surg; 2015 Sep; 136(3):310e-318e. PubMed ID: 26313835
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsurgical Jaw Contouring: A Multi-Faceted Approach.
    Parsa KM; Somenek M
    Facial Plast Surg Clin North Am; 2022 Aug; 30(3):399-406. PubMed ID: 35934441
    [No Abstract]   [Full Text] [Related]  

  • 43. Multimodal Approach for Treating Horizontal Neck Wrinkles Using Intensity Focused Ultrasound, Cohesive Polydensified Matrix Hyaluronic Acid, and IncobotulinumtoxinA.
    Jeon H; Kim T; Kim H; Cho SB
    Dermatol Surg; 2018 Mar; 44(3):421-431. PubMed ID: 28902030
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.
    Goldman ND; Dorton LH; Marcum KK; Gilbert RM; Sandoval LF
    J Cosmet Dermatol; 2014 Sep; 13(3):224-31. PubMed ID: 25196690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J; Carruthers A; Monheit GD; Davis PG
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparative evaluation of the safety and efficacy of botulinum toxin type A and topical creams for treating moderate-to-severe glabellar rhytids.
    Beer KR
    Dermatol Surg; 2006 Feb; 32(2):184-97. PubMed ID: 16442037
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Botulinum toxin A: its expanding role in dermatology and esthetics.
    Said S; Meshkinpour A; Carruthers A; Carruthers J
    Am J Clin Dermatol; 2003; 4(9):609-16. PubMed ID: 12926979
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of fresh versus refrigerated botulinum toxin in the treatment of lateral periorbital rhytids.
    Hui JI; Lee WW
    Ophthalmic Plast Reconstr Surg; 2007; 23(6):433-8. PubMed ID: 18030112
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Using Google to Trend Patient Interest in Botulinum Toxin and Hyaluronic Acid Fillers.
    Motosko C; Zakhem G; Ho R; Saadeh P; Hazen A
    J Drugs Dermatol; 2018 Nov; 17(11):1245-1246. PubMed ID: 30500150
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hyaluronic acid plus mannitol treatment for improved skin hydration and elasticity.
    Taieb M; Gay C; Sebban S; Secnazi P
    J Cosmet Dermatol; 2012 Jun; 11(2):87-92. PubMed ID: 22672272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B; David M; Jain R; Amselem M; Ruiz-Rodriguez R; Ma MY; Kerrouche N; Georgantopoulos SP; Radeau T; Boineau D
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dermal filler materials and botulin toxin.
    Naoum C; Dasiou-Plakida D
    Int J Dermatol; 2001 Oct; 40(10):609-21. PubMed ID: 11737419
    [No Abstract]   [Full Text] [Related]  

  • 53. Noninferiority of incobotulinumtoxinA, free from complexing proteins, compared with another botulinum toxin type A in the treatment of glabellar frown lines.
    Sattler G; Callander MJ; Grablowitz D; Walker T; Bee EK; Rzany B; Flynn TC; Carruthers A
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2146-54. PubMed ID: 21134045
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffusion and short-term efficacy of botulinum toxin A after the addition of hyaluronidase and its possible application for the treatment of axillary hyperhidrosis.
    Goodman G
    Dermatol Surg; 2003 May; 29(5):533-8; discussion 538. PubMed ID: 12752524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A randomized, multicenter study on a flexible hyaluronic acid filler in treatment of moderate-to-severe nasolabial folds in a Chinese population.
    Xie Y; Wu W; Xu J; Wang X; Hu Z; Li Q
    J Cosmet Dermatol; 2022 Oct; 21(10):4288-4293. PubMed ID: 35279948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Botulinum toxin A treatment of perioral rhytides.
    Semchyshyn N; Sengelmann RD
    Dermatol Surg; 2003 May; 29(5):490-5; discussion 495. PubMed ID: 12752516
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New indications for botulinum toxin type a in cosmetics: mouth and neck.
    Spósito MM
    Plast Reconstr Surg; 2002 Aug; 110(2):601-11; discussion 612-3. PubMed ID: 12142684
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Combination Approach to Perioral Rejuvenation.
    Danhof RS; Cohen JL
    J Drugs Dermatol; 2016 Jan; 15(1):111-2. PubMed ID: 26741389
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Body experience and self-esteem after minimally invasive skin rejuvenation : Study of female patients using botulinum toxin A and/or dermal fillers].
    Scharschmidt D; Preiß S; Brähler E; Fischer T; Borkenhagen A
    Hautarzt; 2017 Dec; 68(12):959-967. PubMed ID: 29052749
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Digital Image Speckle Correlation to Optimize Botulinum Toxin Type A Injection: A Prospective, Randomized, Crossover Trial.
    Verma R; Klein G; Xu Y; Rafailovich M; Gilbert Fernandez JJ; Khan SU; Bui DT; Dagum AB
    Plast Reconstr Surg; 2019 Jun; 143(6):1614-1618. PubMed ID: 31136474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.